MARKET

LIMN

LIMN

Liminatus Pharma
NASDAQ
0.5971
-0.6629
-52.61%
Opening 13:01 02/11 EST
OPEN
1.070
PREV CLOSE
1.260
HIGH
1.100
LOW
0.5834
VOLUME
12.28M
TURNOVER
--
52 WEEK HIGH
33.66
52 WEEK LOW
0.5399
MARKET CAP
16.16M
P/E (TTM)
-6.8553
1D
5D
1M
3M
1Y
5Y
1D
Liminatus Pharma files to sell 6.9M shares of common stock, warrants
TipRanks · 6h ago
Iris Acquisition Corp. II Announces Publication of Unqualified Independent Audit Report
Reuters · 20h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 1d ago
Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 1d ago
Liminatus Pharma Settles Litigation Through Equity Issuance
TipRanks · 1d ago
Liminatus Pharma Agrees To Issue 4M Common Shares To Clear Street As Part Of Settlement
Benzinga · 1d ago
LIMINATUS PHARMA INC - ON FEB 6, CO ENTERS SETTLEMENT AGREEMENT WITH CLEAR STREET LLC - SEC FILING
Reuters · 1d ago
More
About LIMN
Liminatus Pharma, Inc. is a pre-clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies. The Company is engaged in the development of a second generation CD47 blockade antibody designed to prevent the induction of severe anemia and thrombocytopenia observed with first generation CD47 blockades. The Company’s candidate, IBA101, is a humanized anti-CD47 monoclonal antibody. The CD47 checkpoint inhibitor’s initial indication is expected to be patients with advanced solid cancers, including non-small cell lung cancer. IBA101 is a humanized anti-human CD47 monoclonal antibody with a human IgG4 Fc, designed to preferentially bind nucleated cells, such as immune and tumor cells, while sparing anucleate cells like red blood cells and platelets. IBA101 promotes macrophage-mediated phagocytosis of tumor cells.

Webull offers Liminatus Pharma Inc stock information, including NASDAQ: LIMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LIMN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LIMN stock methods without spending real money on the virtual paper trading platform.